COVID-19 Diagnostics Dashboards

Related program: Diagnostics

Interactive tools to support product selection and procurement decisions by aggregating and visualizing publicly available information about the development, supply, regulatory approvals, and performance of COVID-19 diagnostic tests

Large-scale testing and contact tracing are central to efforts to control the COVID-19 pandemic. This relies on diagnostic tests that can rapidly, accurately, and reliably detect SARS-CoV-2. However, with over 1,000 COVID diagnostics tests currently in development or on the market, understanding test quality, performance, and availability at the global and country level is extremely challenging.

Explore other COVID-19 dashboards:

Are details on your test missing from this dashboard?
Request an update

About this resource

A multidisciplinary team at PATH has developed the interactive COVID-19 Diagnostics Dashboard which consolidates publicly available market intelligence to support data-driven procurement and purchasing decisions. This tool is designed to be used by national governments, procurers, funders, and policymakers.

Diagnostics can be searched by diagnostic platform, test performance, regulatory status, country of origin, and commercial availability.

This project is currently being funded by The Access Delivery Partnership.

To be notified about updates to these dashboards please email

Manufacturers are encouraged to email links of publicly available confirmatory lab data that demonstrates their assays work with variants to

Learn more about PATH's diagnostics program.